Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease
- Ihor S. Misko†,
- Simone M. Cross,
- Rajiv Khanna,
- Suzanne L. Elliott,
- Christopher Schmidt,
- Stephanie J. Pye, and
- Sharon L. Silins
- Epstein–Barr Virus Unit, Queensland Institute of Medical Research and Joint Experimental Oncology, University of Queensland, Brisbane, 4029, Australia
-
Edited by Jack Leonard Strominger, Harvard University, Cambridge, MA, and approved November 24, 1998 (received for review October 26, 1998)
Abstract
The immunodominant, CD8+ cytotoxic T lymphocyte (CTL) response to the HLA-B8-restricted peptide, RAKFKQLL, located in the Epstein–Barr virus immediate-early antigen, BZLF1, is characterized by a diverse T cell receptor (TCR) repertoire. Here, we show that this diversity can be partitioned on the basis of crossreactive cytotoxicity patterns involving the recognition of a self peptide—RSKFRQIV—located in a serine/threonine kinase and a bacterial peptide—RRKYKQII—located in Staphylococcus aureus replication initiation protein. Thus CTL clones that recognized the viral, self, and bacterial peptides expressed a highly restricted αβ TCR phenotype. The CTL clones that recognized viral and self peptides were more oligoclonal, whereas clones that strictly recognized the viral peptide displayed a diverse TCR profile. Interestingly, the self and bacterial peptides equally were substantially less effective than the cognate viral peptide in sensitizing target cell lysis, and also resulted only in a weak reactivation of memory CTLs in limiting dilution assays, whereas the cognate peptide was highly immunogenic. The described crossreactions show that human antiviral, CD8+ CTL responses can be shaped by peptide ligands derived from autoantigens and environmental bacterial antigens, thereby providing a firm structural basis for molecular mimicry involving class I-restricted CTLs in the pathogenesis of autoimmune disease.
Footnotes
-
↵ † To whom reprint requests should be addressed. e-mail: ihorM{at}qimr.edu.au.
-
This paper was submitted directly (Track II) to the Proceedings Office.
-
Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. AJ235202–AJ235225).
- ABBREVIATIONS:
- EBV,
- Epstein–Barr virus;
- CTL,
- cytotoxic T lymphocyte;
- LCL,
- lymphoblastoid cell line;
- TCR,
- T cell receptor;
- BZLF1,
- EBV immediate-early antigen;
- PBMC,
- peripheral blood mononuclear cell;
- RAK,
- RAKFQLL (residues 190–197);
- RSK,
- RSKFRQIV (residues 156–163);
- RRK,
- RRKYKQII (residues 269–276);
- V-(D)-J,
- variable-diversity-joining;
- CDR3,
- compatibility determining region 3;
- MHC,
- major histocompatibility complex;
- PHA,
- phytohemagglutinin
- Copyright © 1999, The National Academy of Sciences





